Jordans, C. C. E.
Vliegenthart-Jongbloed, K. J.
van Bruggen, A. W.
van Holten, N.
van Beek, J. E. A.
Vriesde, M.
van der Sluis, D.
Verbon, A.
Roukens, A. H. E.
Stutterheim, S. E.
Rokx, C.
Funding for this research was provided by:
SKMS (59825822)
Article History
Accepted: 29 May 2024
First Online: 13 June 2024
Declarations
:
: CJ received travel funding from Gilead Sciences and received speaker funding from ViiV Healthcare, both outside the submitted work, KV is conducting a PhD that is supported by investigator-initiated study grants from Gilead Sciences and ViiV Healthcare, CR received funding for investigator-initiated studies, and reimbursement for travel and participation in scientific advisory boards, from Gilead Sciences and ViiV Healthcare. NH received speaker funding from Gilead Sciences outside the submitted work. The other authors reported no disclosures.